MarketCap
Facebook
X
Telegram
Epizyme Historical Prices | EPZM
Annual Historical Prices Epizyme
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.23 | 10.9 | 20.9 | 10.2 | 16.1 | 10.5 | 9.09 | 19.1 | 30.4 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 30.4 | 1.23 | 14.3 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Fennec Pharmaceuticals
FENC
|
5.91 | $ 10.12 | 0.4 % | $ 289 M |  USA |
 |
Foghorn Therapeutics
FHTX
|
5.65 | $ 2.04 | 2.0 % | $ 128 M | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
14.7 | $ 13.76 | 4.13 % | $ 11.5 B |  India |
 |
Arcturus Therapeutics Holdings
ARCT
|
7.93 | $ 9.91 | 0.71 % | $ 271 M |  Israel |
 |
Sanofi
SNY
|
48.6 | $ 41.77 | 0.41 % | $ 51 B |  France |
 |
Arcutis Biotherapeutics
ARQT
|
27.1 | $ 31.74 | 1.73 % | $ 4.04 B | USA |
 |
Geron Corporation
GERN
|
1.59 | $ 1.15 | 2.23 % | $ 767 M | USA |
 |
Gossamer Bio
GOSS
|
0.47 | $ 9.2 | -4.27 % | $ 2.1 B | USA |
 |
Titan Pharmaceuticals
TTNP
|
6.96 | - | -3.76 % | $ 3.47 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.383 | - | 3.16 % | $ 1.9 M | USA |
 |
ALX Oncology Holdings
ALXO
|
2.13 | $ 1.14 | -2.56 % | $ 61.2 M | USA |
 |
Heron Therapeutics
HRTX
|
1.19 | $ 0.3 | -0.46 % | $ 50 M | USA |
 |
Achieve Life Sciences
ACHV
|
2.9 | $ 6.55 | 0.85 % | $ 286 M | USA |
 |
TCR2 Therapeutics
TCRR
|
1.5 | - | - | $ 58.1 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
13.8 | $ 17.02 | 0.98 % | $ 2.29 B |  Canada |
 |
iBio
IBIO
|
1.36 | $ 0.71 | -1.28 % | $ 73.9 M | USA |
 |
ImmuCell Corporation
ICCC
|
6.43 | $ 10.21 | -0.37 % | $ 92.2 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
43.7 | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
Inhibikase Therapeutics
IKT
|
1.63 | $ 1.51 | -5.03 % | $ 148 M | USA |
 |
Immunome
IMNM
|
21.6 | $ 17.89 | -0.54 % | $ 1.56 B | USA |
|
TFF Pharmaceuticals
TFFP
|
6.05 | - | -60.05 % | $ 125 K | USA |
 |
InMed Pharmaceuticals
INM
|
1.31 | $ 1.57 | 9.03 % | $ 6.54 M | Canada |
 |
Inovio Pharmaceuticals
INO
|
2.1 | $ 0.88 | -1.82 % | $ 41.3 M | USA |
 |
Innoviva
INVA
|
24.1 | $ 21.06 | 1.91 % | $ 1.42 B | USA |
 |
Iovance Biotherapeutics
IOVA
|
3.78 | $ 13.78 | -2.24 % | $ 4.92 M | USA |
 |
Theratechnologies
THTX
|
1.65 | - | - | $ 83.9 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.7 | - | -15.15 % | $ 60.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
3.54 | - | - | $ 521 M | USA |
 |
Axon Enterprise
AXON
|
392 | $ 424.81 | 1.06 % | $ 33.2 B | USA |
 |
Axcella Health
AXLA
|
0.46 | - | -16.42 % | $ 249 M | USA |
 |
Keros Therapeutics
KROS
|
13.8 | $ 11.35 | 0.62 % | $ 422 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
13.3 | - | - | $ 2.02 B | USA |
 |
Legend Biotech Corporation
LEGN
|
18.8 | $ 20.39 | 5.79 % | $ 7.52 B | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
102 | $ 308.16 | 1.53 % | $ 5.96 B | USA |
 |
BridgeBio Pharma
BBIO
|
68.4 | $ 68.11 | -0.65 % | $ 13 B | USA |
 |
Annovis Bio
ANVS
|
2.52 | $ 0.95 | -4.92 % | $ 19.5 M | USA |
 |
Liquidia Corporation
LQDA
|
34.2 | $ 43.75 | 2.58 % | $ 3.77 B | USA |
 |
Tyme Technologies
TYME
|
0.309 | - | 8.07 % | $ 54 M | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
1.63 | $ 1.46 | 2.81 % | $ 530 M | USA |
 |
Mustang Bio
MBIO
|
0.85 | $ 0.36 | -1.89 % | $ 1.77 M | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
10.7 | $ 7.88 | 3.01 % | $ 1.65 B | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
441 | $ 437.59 | 0.77 % | $ 9.82 B | USA |
 |
Cyclerion Therapeutics
CYCN
|
3.08 | $ 34.99 | 3.77 % | $ 147 M | USA |
 |
Black Diamond Therapeutics
BDTX
|
2.19 | $ 1.69 | -10.37 % | $ 96.1 M | USA |
 |
Mirum Pharmaceuticals
MIRM
|
109 | $ 83.44 | 3.79 % | $ 4.19 B | USA |
 |
Aptevo Therapeutics
APVO
|
4.51 | $ 1.49 | -7.45 % | $ 470 K | USA |
 |
MannKind Corporation
MNKD
|
3.24 | $ 3.23 | 1.25 % | $ 987 M | USA |
|
Monopar Therapeutics
MNPR
|
54.1 | $ 70.52 | -0.18 % | $ 523 M | USA |
 |
Marker Therapeutics
MRKR
|
1.34 | $ 0.9 | -6.16 % | $ 13.8 M | USA |
 |
Maravai LifeSciences Holdings
MRVI
|
2.13 | $ 7.5 | 3.69 % | $ 1.08 B | USA |